HeyJaredKamal Choudhury
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 14, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Aug 18, 2026
Latest articles
Definium's LSD-based Drug Lowers Anxiety in New Late-stage Trial, Shares Soar (opens the original)
Read excerpt
Sept 14 (Reuters) - Definium Therapeutics said its LSD-based treatment reduced symptoms of generalized anxiety disorder in a second successful late-stage study, sending shares soaring nearly 20% in premarket trading on Monday. A single 100-microgram dose of DT120, a fast-dissolving tablet of lysergide, or LSD, reduced scores on an anxiety scale by 9.8 points after 12 weeks, compared with a 4.7-point decline for placebo, the company said. Regulatory and investor enthusiasm for psychedelic-bas
Amylyx Drug Cuts Low Blood Sugar Episodes in Bariatric Surgery Patients in Key Trial (opens the original)
Read excerpt
Aug 18 (Reuters) - Amylyx Pharmaceuticals' experimental drug sharply reduced dangerously low blood sugar episodes in a late-stage trial of patients who underwent weight-loss surgery, sending its shares up more than 45% on Tuesday. There are no approved treatments for post-bariatric hypoglycemia, a condition that can develop after Roux-en-Y gastric bypass, a common weight-loss procedure, and can cause cognitive impairment, loss of consciousness or seizures. In the 78-patient trial, avexitide,
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.